What happens during an allergic reaction? This podcast explains how IgE antibodies and histamine trigger symptoms, plus the difference between allergies and intolerances.

Learn about Neffy, the epinephrine nasal spray for anaphylaxis. This episode addresses questions and skepticism about this groundbreaking, needle-free option.

Learn about Neffy, the new FDA-approved nasal spray for epinephrine. Discover how it works, its unique benefits for anaphylaxis, and insights on its approval process.

We are talking about health insurance open enrollment! This episode covers networks, premiums, and pharmacy benefits to help you choose the right health insurance plan for your needs.

Discover life with chronic urticaria in skin of color as Meka shares her journey from diagnosis to advocacy and finding support to manage hives on darker skin.

How do hives look in skin of color, and why are diagnoses often delayed? In this episode, we explore unique barriers, lack of visual aids, and the need for culturally sensitive care to improve outcomes.

Are you a healthcare provider frustrated by the health insurance approval process? This episode unpacks how healthcare providers can navigate health insurance, from documentation and prior authorizations to overcoming medication denials.

This episode explores health insurance, covering how to collaborate with your doctor on paperwork, what a prior authorization is and what steps to take if a medication is denied.

We discuss the science behind 8 biologics available for allergic diseases , how they work and the long process for approval for various diseases.

We unpack how to start biologic therapy with confidence: covering insurance, specialty pharmacies, and tips for a smooth treatment journey.

Discover the truth behind common biologic medication myths with Dr. Rutland. Learn how biologics work and why they’re changing treatment for asthma and eczema.

Biologic medications are an exciting advancement in medicine. Learn how biologic therapy works and how these treatments improve quality of life for patients with asthma and other allergic diseases.

Explore the future of Chronic Spontaneous Urticaria (CSU) treatment. In this episode, we delve into groundbreaking advancements, including emerging biologics and therapies that promise to transform the landscape of CSU care: Dupilumab, Remibrutinib, and Barzolvolimab. We also discuss Omalizumab, a current treatment option, and the evolving understanding of CSU's root cause.